CH
PROF

CVI Holdings’s Profound Medical PROF Stock Holding History

CVI Holdings’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$146K – 971
2021
Q3 		$146K Buy
+10,000
New +$152K 0.01% 563

Other funds holding PROF

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

CVI Holdings's PROF Position: Q4 2021 in Review

CVI Holdings sold out of Profound Medical (PROF) in Q4 2021, closing a stake of 10,000 shares — an estimated $146K sold.

CVI Holdings first reported a position in PROF in Q3 2021 and held it in 1 quarter. The position peaked at $146K in Q3 2021. 46 funds tracked by Wall St. Rank hold PROF as of Q4 2021.

  • CVI Holdings reported no remaining Profound Medical position as of Q4 2021 after selling out during the quarter.
  • CVI Holdings sold 10,000 Profound Medical shares in Q4 2021, an estimated $146K.
  • CVI Holdings first reported a position in Profound Medical in Q3 2021 and held it in 1 quarter.
  • CVI Holdings's Profound Medical position peaked at $146K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Profound Medical as of Q4 2021.

Based on CVI Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.